BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 18665774)

  • 1. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
    Hotez PJ; Bethony JM; Oliveira SC; Brindley PJ; Loukas A
    Expert Rev Vaccines; 2008 Aug; 7(6):745-52. PubMed ID: 18665774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinomics for the major blood feeding helminths of humans.
    Loukas A; Gaze S; Mulvenna JP; Gasser RB; Brindley PJ; Doolan DL; Bethony JM; Jones MK; Gobert GN; Driguez P; McManus DP; Hotez PJ
    OMICS; 2011 Sep; 15(9):567-77. PubMed ID: 21679087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hookworm and poverty.
    Hotez P
    Ann N Y Acad Sci; 2008; 1136():38-44. PubMed ID: 17954674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New technologies for the control of human hookworm infection.
    Hotez PJ; Bethony J; Bottazzi ME; Brooker S; Diemert D; Loukas A
    Trends Parasitol; 2006 Jul; 22(7):327-31. PubMed ID: 16709466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of helminths: nonreplicating infectious agents of man.
    Warren KS
    Annu Rev Public Health; 1981; 2():101-5. PubMed ID: 6890842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
    Bottazzi ME; Brown AS
    Expert Rev Vaccines; 2008 Dec; 7(10):1481-92. PubMed ID: 19053205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not by drugs alone: the fight against parasitic helminths.
    Evans AC; Stephenson LS
    World Health Forum; 1995; 16(3):258-61. PubMed ID: 7546164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.
    Pearson MS; Pickering DA; Tribolet L; Cooper L; Mulvenna J; Oliveira LM; Bethony JM; Hotez PJ; Loukas A
    J Infect Dis; 2010 May; 201(10):1561-9. PubMed ID: 20367477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunology of human hookworm infections.
    McSorley HJ; Loukas A
    Parasite Immunol; 2010 Aug; 32(8):549-59. PubMed ID: 20626810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neglected tropical disease vaccines.
    Hotez PJ; Brown AS
    Biologicals; 2009 Jun; 37(3):160-4. PubMed ID: 19278869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008.
    Fenwick A; Webster JP; Bosque-Oliva E; Blair L; Fleming FM; Zhang Y; Garba A; Stothard JR; Gabrielli AF; Clements AC; Kabatereine NB; Toure S; Dembele R; Nyandindi U; Mwansa J; Koukounari A
    Parasitology; 2009 Nov; 136(13):1719-30. PubMed ID: 19631008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in vaccine research against schistosomiasis in Brazil.
    Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC
    Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hookworm infection and disease: advances for control.
    Albonico M; Savioli L
    Ann Ist Super Sanita; 1997; 33(4):567-79. PubMed ID: 9616967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hookworm vaccines.
    Diemert DJ; Bethony JM; Hotez PJ
    Clin Infect Dis; 2008 Jan; 46(2):282-8. PubMed ID: 18171264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
    Hotez PJ; Zhan B; Bethony JM; Loukas A; Williamson A; Goud GN; Hawdon JM; Dobardzic A; Dobardzic R; Ghosh K; Bottazzi ME; Mendez S; Zook B; Wang Y; Liu S; Essiet-Gibson I; Chung-Debose S; Xiao S; Knox D; Meagher M; Inan M; Correa-Oliveira R; Vilk P; Shepherd HR; Brandt W; Russell PK
    Int J Parasitol; 2003 Sep; 33(11):1245-58. PubMed ID: 13678639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing vaccines to combat hookworm infection and intestinal schistosomiasis.
    Hotez PJ; Bethony JM; Diemert DJ; Pearson M; Loukas A
    Nat Rev Microbiol; 2010 Nov; 8(11):814-26. PubMed ID: 20948553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis elimination: lessons from the past guide the future.
    Gray DJ; McManus DP; Li Y; Williams GM; Bergquist R; Ross AG
    Lancet Infect Dis; 2010 Oct; 10(10):733-6. PubMed ID: 20705513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosomiasis vaccine development--the current picture.
    Waine GJ; McManus DP
    Bioessays; 1997 May; 19(5):435-43. PubMed ID: 9174407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hookworm infections in human and laboratory animals--differences and similarities in immune responses.
    Długosz E
    Wiad Parazytol; 2005; 51(3):219-25. PubMed ID: 16913526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human anthelminthic vaccines: Rationale and challenges.
    Hotez PJ; Strych U; Lustigman S; Bottazzi ME
    Vaccine; 2016 Jun; 34(30):3549-55. PubMed ID: 27171753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.